The science here is settled, and it's negative. 225 men took 320 mg a day or placebo for a year: no difference on symptoms, urine flow, or prostate size 1. A second trial pushed the dose to 640 and 960 mg over eighteen months. Clinical improvement was 43% on saw palmetto, 44% on placebo 2. The improvement men feel is the brain's expectation, not the plant. For pattern hair loss the evidence is thinner but points the same way.
The mechanism is real; the effect isn't. Saw palmetto does block the enzyme that makes DHT, the hormone behind both an enlarging prostate and hair loss. Measured inside the gland by biopsy, prostate DHT fell 32% on it 3. Finasteride dropped it 80%, and halved blood DHT while saw palmetto left the blood untouched. So there's a plant compound doing something. It's just too weak to change how often you get up at night.
What actually works, if a urologist has called it BPH: alpha-blockers like tamsulosin relax the bladder neck and help within days. Finasteride and dutasteride shrink the prostate a fifth over six months and cut the long-term risk of retention and surgery 4. The two together cut the odds of getting worse by two-thirds over four years 4. For hair, minoxidil and oral finasteride carry decades of trials; treat saw palmetto as an add-on to those, never a swap.
Taking it anyway? Cap the experiment so it can't waste your year.
The cost of waiting isn't zero. An enlarging prostate doesn't sit still. Six to twelve months of a supplement that isn't working is six to twelve months the stream keeps slowing, and a subset of men progress to acute urinary retention — the 2 a.m. emergency-room kind. One real convenience: unlike finasteride, saw palmetto doesn't distort your PSA, so cancer screening stays clean 5.
The fine print — when to skip it, and what people get wrong
"Natural finasteride" is the wrong label: finasteride cuts blood DHT 60–70%; saw palmetto doesn't measurably touch it and has high-certainty evidence of no BPH benefit. It also won't prevent prostate cancer or treat prostatitis.
Safety is genuinely good; side-effect rates match placebo out to eighteen months 6. Still, stop it two weeks before surgery and skip it on warfarin, aspirin, or another blood thinner, where case reports describe prolonged bleeding.
- 1Bent S, Kane C, Shinohara K, et al. (2006). Saw palmetto for benign prostatic hyperplasia. New England Journal of Medicine. link
- 2Barry MJ, Meleth S, Lee JY, et al. (2011). Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial (CAMUS). JAMA. link
- 3Marks LS, Hess DL, Dorey FJ, et al. (2001). Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology. link
- 4McConnell JD, Roehrborn CG, Bautista OM, et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia (MTOPS). New England Journal of Medicine. link
- 5Andriole GL, McCullum-Hill C, Sandhu GS, et al. (2013). The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. Journal of Urology. link
- 6Avins AL, Lee JY, Meyers CM, Barry MJ; CAMUS Study Group (2013). Safety and toxicity of saw palmetto in the CAMUS trial. Journal of Urology. link
დაკავშირებული სახელმძღვანელოში (5)
- — Saw palmetto imitates finasteride's mechanism weakly; the prescription is the version with the evidence behind it.
- — People hoping to skip finasteride after a transplant reach for saw palmetto, but the big trials don't back it.
- — Before assuming a supplement like saw palmetto will help nighttime urination, figure out whether it's even the prostate.
- — Minoxidil is a first-line hair treatment; saw palmetto is a much weaker option people reach for instead.
- — Men reaching for a prostate supplement should also sort out the actual screening question, which it can't answer.
Saw Palmetto (Serenoa repens)
One 320 mg capsule daily with food. No timing complexity, no titration, no monitoring.
Among the better-evidenced negative findings in supplement medicine: two large NIH-funded placebo-controlled RCTs (STEP 2006, CAMUS 2011 up to 3× dose), two consecutive Cochrane meta-analyses (2012, 2023) at high-to-moderate certainty, AUA guideline alignment. The data are strong; the answer they give is null.
Standardized 320 mg/day costs ~$10–25/month at retail (~$120–300/year). Bulk and store-brand options drop the low end toward $50–80/year; verified third-party-tested products push toward $300.
Small AGA signal across three modest trials — Prager 2002 (n=26), Rossi 2012 (open-label, 38% regrowth vs 68% on finasteride), Sudeep 2023 (industry-authored, n=80). Direction consistent; magnitude small; evidence weak. Not the reason you'd recommend it.